(Q36217248)

12 August 2017

title

Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease (English)

1 reference

non-alcoholic fatty liver

12 August 2017

main subject

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

Jeanne M Clark

1

1 reference

12 August 2017

Amir R A Alkhuraishi

2

1 reference

12 August 2017

Steven F Solga

3

1 reference

12 August 2017

Patricia Alli

4

1 reference

12 August 2017

Anna Mae Diehl

5

1 reference

12 August 2017

Thomas H Magnuson

6

1 reference

12 August 2017

publication date

1 July 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

13

1 reference

12 August 2017

issue

7

1 reference

12 August 2017

page(s)

1180-1186

1 reference

Prevalence and Trends in Obesity Among US Adults, 1999-2000

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Prevalence and Predictors of Asymptomatic Liver Disease in Patients Undergoing Gastric Bypass Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Current status of medical and surgical therapy for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Hepatic effects of dietary weight loss in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Effect on Hepatic Morphology of Treatment of Obesity by Fasting, Reducing Diets and Small-Bowel Bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Cytokines and the molecular mechanisms of alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Cytokine regulation of liver injury and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Cytokines in alcoholic and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Metformin in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Gastric bypass for treating severe obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Late outcome of isolated gastric bypass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Hepatic effects of jejunoileal bypass for morbid obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Liver morphology and function tests in obesity and during total starvation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Pathogenesis of Nutritional Cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Pattern of progression in liver injury following jejunoileal bypass for morbid obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Gastric bypass for morbid obesity: a medical--surgical assessment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Regression of Hepatic Steatosis in Morbidly Obese Persons After Gastric Bypass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Biliopancreatic diversion for obesity at eighteen years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

Malabsorptive procedures for severe obesity: comparison of pancreaticobiliary bypass and very very long limb Roux-en-Y gastric bypass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.140

31 March 2020

Identifiers

DOI

10.1038/OBY.2005.140

1 reference

12 August 2017

1 reference